(Circulation. 2001;103:e1.)
© 2001 American Heart Association, Inc.
Current Perspective |
From the Universität Leipzig, Herzzentrum GmbH, Klinik für Innere Medizin/Kardiologie, Leipzig, Germany.
Correspondence to Priv-Doz Dr med Rainer Hambrecht, Associate Professor of Medicine, Universität Leipzig - Herzzentrum GmbH, Department of Internal Medicine/Cardiology, Russenstr 19, 04289 Leipzig, Germany. E-mail hamr{at}server3.medizin.uni-leipzig.de
| Abstract |
|---|
|
|
|---|
Key Words: endothelium exercise coronary disease vasculature microcirculation
| Introduction |
|---|
|
|
|---|
Basically, regional myocardial hypoperfusion in CAD results from a combination of 3 pathogenetic components: (1) vascular stenosis, (2) microvascular dysfunction, and (3) microrheology and hemostasis. All 3 components may be affected by exercise training in patients with stable CAD.
| Regression of Coronary Atherosclerosis |
|---|
|
|
|---|
The Lifestyle Heart Trial analyzed the effect of lifestyle changes, including a strictly vegetarian diet, stress-management techniques, smoking cessation, and 3 hours of exercise training per week, on the degree of coronary artery stenosis. In the intervention group, a regression of coronary artery stenoses from 40±17% to 38±17% was observed; in the control group, stenoses increased from 43±16% to 46±19% (P=0.001).3 This difference was even more pronounced at 5-year follow-up. At that point, the intervention group had a 3.1% regression of stenoses (in percent of relative coronary stenosis) compared with an 11.8% progression in the usual care group; this regression was associated with a 2.5-fold risk reduction in cardiac events.4
In the Stanford Coronary Risk Intervention Project, 300 patients with CAD were randomly assigned to receive either the usual care or multifactorial risk reduction, including a low-fat diet, lipid-lowering medication, and exercise training. Serial coronary angiograms on a yearly basis showed an attenuation of disease progression in the intervention arm, with a decline in minimal luminal diameter by 0.024±0.067 mm/year compared with a regression of 0.045±0.073 mm/year in the control group (P<0.02).5 Over the study period of 4 years, 25 cardiac events occurred in the intervention group and 44 occurred in the control group.
In the Heidelberg Regression Study, 113 patients with documented CAD were randomly assigned to a bifactorial intervention with a low-fat diet and regular physical exercise or to a control group. This regimen was effective in halting the progression of coronary atherosclerosis.6 After 1 year, the mean luminal diameter was unchanged in the training group (0.0±0.038 mm), but it decreased in the usual care group by 0.13±0.045 mm (P<0.05). At 6-year follow-up, the progression of CAD was still significantly retarded in the training group.7 In a retrospective analysis, a correlation between exercise-associated energy expenditure and change in minimal stenosis diameter revealed that a regression of coronary stenosis may only be expected when using >2200 kcal/week, which is equivalent to 5 to 6 hours of regular physical exercise per week.8 This finding makes the regression of coronary stenoses an unlikely mechanism to explain the improved myocardial perfusion in the majority of patients who undergo exercise training.
In summary, multifactorial lifestyle changes, including reducing cholesterol and improving exercise training, can attenuate the progression of coronary stenoses. However, the comparatively small morphometric changes observed in coronary diameter make it difficult for this factor to explain the substantial increase in myocardial perfusion and angina threshold associated with training interventions. From todays perspective, it may be that the use of intravascular ultrasound, which permits a more accurate assessment of plaque volume than conventional angiography, would have yielded different results.
| Formation of Collaterals |
|---|
|
|
|---|
In humans, data derived from clinical studies are equally controversial. In a subgroup analysis of an 8-week exercise training trial in ischemic cardiomyopathy involving 23 patients, Belardinelli et al12 found a significant increase in coronary collateralization as quantified by visual classification of the retrograde filling of the infarct-related vessel.
In the Heidelberg Regression Study, which involved patients with stenotic CAD and preserved left ventricular function, however, no increase in angiographically visible collateralization was observed in long-term follow-up after 1 year of exercise training.13 It may well be that (1) angiography is not sensitive enough to detect the formation of small intramyocardial collateral vessels that will be recruited only during exercise and (2) the stimuli for collateralization are different in patients with stenotic CAD and stable angina pectoris and postinfarction patients with complete vessel occlusion and reduced left ventricular function.
| Endothelial Dysfunction in Coronary Conduit Vessels |
|---|
|
|
|---|
Alterations in coronary vascular endothelial function were first described in 1986, when Ludmer et al14 observed a paradoxical vasoconstriction of atherosclerotic segments after infusing acetylcholine into the left coronary artery of patients with atypical chest pain. The observation that major coronary risk factors are associated with coronary endothelial dysfunction even before circumscript stenoses are visible has led to the concept that endothelial dysfunction occurs at the early stages of atherosclerosis as a conditio sine qua non for atherogenesis.
Pathophysiology of Endothelial
Dysfunction
Coronary vasomotion is influenced by mechanical and
agonist-mediated stimuli, both of which converge on endothelial nitric
oxide (NO) synthesis/release as the final common pathway.
Endothelial dysfunction occurs as a result of decreased bioactive NO
concentrations at vascular smooth muscle cells.
NO concentrations can be affected by alterations at the following different steps of its pathway: (1) availability of the precursor molecule L-arginine; (2) alterations of NO synthesis rate, as determined by endothelial NO synthase (eNOS) conformational changes, expression, or genetic polymorphism; and (3) differences in NO breakdown velocity related to reactive oxidative species (ROS) once it is released.15
L-Arginine
The availability of L-arginine at the active site of
eNOS depends on several factors: (1) exogenous supply with L-arginine
or endogenous L-arginine synthesis; (2) intracellular accumulation of
L-arginine, which depends on active cytokine-regulated transmembranous
transport16 ; (3)
intracellular degradation of L-arginine by arginase to ornithine and
urea; and (4) the presence of the antagonist asymmetric dimethyl
arginine, which blocks NO synthesis from L-arginine. Asymmetric
dimethyl arginine is present in patients with peripheral vascular
disease17 and chronic renal
failure.18
To date, it remains unclear which of these mechanisms are involved in the development of endothelial dysfunction in coronary atherosclerosis, and clinical data are also contradictory. Although L-arginine supplementation improves vascular function in hypercholesterolemia and chronic heart failure,19 20 21 it has no effect in patients with stable CAD.22
eNOS
The activity of eNOS can be altered in response to
short-term stimuli by conformational changes. Michel and
Feron23 proposed that eNOS
association with caveolin suppresses the enzyme activity in the
unactivated endothelial cell. Agonist activation increases
intracellular calcium concentration via cGMP-dependent mechanisms, thus
promoting calmodulin binding to eNOS and dissociation from caveolin.
The activated eNOS-calmodulin complex synthesizes NO until
[Ca2+]i
decreases below a level necessary to sustain calmodulin binding.
Calmodulin dissociates, and the inhibitory eNOS-caveolin complex
reforms.24
Because NO is released via plasmalemmal caveolae, eNOS is targeted to this subcellular compartment by enzyme acylation,25 which may occur as reversible palmitoylation or irreversible myristoylation. Prolonged eNOS activation leads to depalmitoylation of the enzyme, translocation away from the caveolae, phosphorylation, and rebinding of the inhibitory caveolin.23 It remains unclear how this regulation of enzymatic activity is affected by the pathological conditions of endothelial dysfunction.
More is known about long-term conditions like exposure to
high levels of tumor necrosis factor-
, oxidized LDL, and hypoxia,
all of which have been shown to lower eNOS expression in cultured
endothelial cells.26 In
atherosclerosis, eNOS expression is significantly reduced, indicating
that this downregulation may be an important factor for the
pathogenesis of endothelial
dysfunction.27
Genetic polymorphisms of eNOS were recently described as prevalent in certain patients (eg, in hypertensive Japanese).28 However, whether polymorphisms of eNOS result in alterations of enzyme activity remains controversial.
NO Breakdown
Atherosclerosis and endothelial dysfunction are
associated with increased levels of ROS (ie, ·OH,
H2O2).29
These highly reactive radicals accelerate the extracellular degradation
of secreted NO by forming peroxynitrite. Adventitial NADPH oxidases
produce quantities of superoxide high enough to affect endothelial
function.30 This mechanism
has been confirmed in CAD in intervention studies with antioxidants.
For example, in patients with CAD, the long-term administration of
ascorbic acid (vitamin C), a natural radical scavenger, reverses
endothelial
dysfunction.31
However, the underlying mechanism is more complex. Vascular smooth muscle cells produce and set free a potent antioxidative enzyme, the extracellular superoxide dismutase (ecSOD), which is reduced in CAD and correlates with flow-dependent vasodilation of the radial artery in vivo.32 In human aortic smooth muscle cell cultures and organoid cultures of mouse aorta, the NO donor diethylenetriamine-NO (DETA-NO) enhances ecSOD expression in a time- and dose-dependent fashion.33 This finding is consistent with the hypothesis that endothelium-derived NO stimulates the expression and release of ecSOD from vascular smooth muscle cells. Training seems to have similar effects on ecSOD.33 34
Shear Stress and Endothelial Function:
Experimental Data
Shear stress is an important component of exercise, and
it affects vascular NO concentrations on all 3 levels responsible for
the development of endothelial dysfunction discussed above.
L-Arginine
Shear stress increases the velocity of the endothelial
high-affinity/low-capacity transport system for
L-arginine.35 This ensures
substrate availability as the rate-limiting step of eNOS, which
generates ROS in the absence of L-arginine.
eNOS
As early as 60 minutes after the initiation of
shear stress, bovine aortic endothelial cells produce 13 times more NO
compared with baseline
conditions.36 This increase
seems to be mediated by both short-term enhancement of eNOS activity
and the activation of eNOS expression. Shear stress leads to eNOS
phosphorylation on serine residues independent from increases in
[Ca2+]i, which may
modulate enzyme activity.36
Recently, a shear stressactivated signal transduction cascade
involving phosphatidyl-inositol-3-kinase and the serine/threonine
kinase Akt has been identified; it causes
[Ca2+]i-independent
eNOS phosphorylation and
activation.37 38
A considerable increase of eNOS expression has been demonstrated in endothelial cell-culture experiments after 6 hours of exposure to laminar shear stress.39 40 This is consistent with animal studies of exercise training in dogs, which documented increased eNOS expression and NO production in coronary conduit41 and resistance vessels.42 Increases in NOS expression are proportional to the extent of laminar shear stress applied, but they are abolished by turbulent flow.40
However, the presence of 2 alleles of the eNOS gene seems to be necessary to increase eNOS expression in response to exercise training. In mice heterozygotic for a loss of the eNOS gene, no increased eNOS protein expression could be observed in the aorta, whereas wild-type eNOS+/+ mice had a 2.5±0.4-fold increase.34
NO Breakdown
It has long been enigmatic why exercise training, which
increases total oxygen uptake and in turn the production of
ROS,43 can improve
endothelial function. As mentioned above, it was recently shown that
endothelium-derived NO increases the expression of ecSOD in vascular
smooth muscle cells.33 In
the same publication, the authors demonstrated that exercise training
increased both eNOS and ecSOD in wild-type mice, whereas ecSOD remained
unchanged in mice lacking eNOS. This suggests that the effect of
training on ecSOD is mediated by endothelium-derived
NO.
Effects of Exercise Training on Endothelial
Dysfunction in Conduit Vessels
In a recently published prospective clinical study, 19
patients with coronary endothelial dysfunction, as documented by
acetylcholine-induced vasoconstriction, were prospectively randomized
to a training (10 patients) or control group (9 patients). At baseline
and after 4 weeks, endothelium-mediated vasodilation was assessed after
intracoronary infusions of acetylcholine (0.072, 0.72, and 7.2 µg per
minute). The average peak flow velocity was measured using a Doppler
wire, and vessel diameter was assessed by quantitative coronary
angiography.
At baseline, both groups had similar constrictive responses to acetylcholine. After 4 weeks of intensive physical training, acetylcholine-induced coronary artery constriction was attenuated by 54% after the administration of 7.2 µg/min acetylcholine (from -0.41±0.05 to -0.19±0.07 mm; P<0.05 versus control). In training patients, the change in average peak flow velocity in response to 7.2 µg/min acetylcholine increased from 78±16% at the initial study to 142±28% after 4 weeks (P<0.01 versus control).44 This trial documented, for the first time, that exercise training attenuates paradoxical vasoconstriction in response to acetylcholine and improves the endothelial function of coronary conduit vessels in patients with CAD.
While the study by Hambrecht et al44 enrolled patients with nonocclusive stable CAD, Griffin et al45 used an animal model of subacute coronary occlusion by amaroid constrictor in pigs to assess the effects of 16 weeks of exercise training on endothelium-dependent vasorelaxation after long-term coronary occlusion. Even in artery segments distal to the constrictor, they observed a markedly enhanced NO-mediated relaxation, which basically confirmed the results in patients with nonstenotic CAD.
| Coronary Resistance Vessels and Microcirculation |
|---|
|
|
|---|
Effects of Exercise Training on the
Microcirculation
Exercise training increases resistance vessel
sensitivity and maximal responsiveness to adenosine in dogs in
vivo.49 These results also
suggest that training alters the responses of coronary artery smooth
muscle to metabolic vasodilators. In line with this hypothesis, Muller
et al50 found an increased
myogenic response of coronary resistance arteries from exercise-trained
swine for intraluminal pressures >40 mm Hg. After exercise training,
adenosine-mediated arteriolar permeability for porcine serum albumin
increased by 65%, indicating a higher vascular
permeability.51
Long-term exercise training induces functional and morphological changes in the microvasculature. White et al52 conclusively showed in a porcine model of exercise training that training increases the total vascular bed cross-sectional area by up to 37% after 16 weeks. As a consequence, vascular resistance decreases and maximal flow reserve rises.
Hambrecht et al44 assessed changes in microvascular function by measuring the coronary flow reserve ratio in response to adenosine. Training patients had a 29% increase in coronary flow reserve after exercise training (from 2.8±0.2 to 3.6±0.2; P<0.01 versus control), which also indicated an enhanced sensitivity of the coronary microcirculation to adenosine.
| Microrheology and Platelet Function |
|---|
|
|
|---|
Short-term bouts of strenuous exercise may have thrombogenic
side effects because platelet number and activity are
increased.55 Long-term
exercise training, however, attenuates this potentiation of platelet
function and increases platelet cGMP
content.56 Physical training
seems to suppress coagulability, as indicated by the decrease in
fibrinogen, factor VIII:C, von Willebrand factor, factor VII:C, and
thrombin-antithrombin III complex and the prolongation of activated
partial thromboplastin time. The decrease of anticoagulatory factors
like plasminogen, tissue plasminogen activator antigen,
2-plasmin inhibitor, plasminogen activator
inhibitor-1, and plasmin-
2PI complex after physical training may
result from decreased
coagulability.57 In summary,
a net reduction of thrombogenic risk in CAD by exercise training has
been documented.
| Future Aspects |
|---|
|
|
|---|
A further open question that might influence future guidelines of exercise training in CAD is the dose-response relationship between the training intensity and the effects on coronary vasomotion. Is there a threshold of either training intensity/duration or trained muscle mass that must be surmounted to achieve improved endothelium-dependent vasodilation?
Recently, the first reports about a possible association between endothelial dysfunction and the frequency of clinical events were published.63 64 Further prospective studies are needed to establish whether endothelial dysfunction is an independent prognostic marker. If so, exercise training may be promoted from a symptomatic intervention to a preventive strategy with long-term prognostic benefits.
| Conclusion |
|---|
|
|
|---|
Keeping these limitations in mind, exercise training
enhances myocardial perfusion by increasing both eNOS and ecSOD
expression, thus attenuating the premature breakdown of NO by ROS.
These increases in both local NO production and half-life improve
endothelium-dependent vasodilation in response to flow or
acetylcholine. It is reasonable to suppose that these functional
changes occur rather rapidly after the initiation of an exercise
training program, although no studies are available on their precise
time course. Anatomic changes like augmentation of the capillary bed
and slowing of the progression of coronary atherosclerosis will require
more extended periods of training
(Figure
).
|
| References |
|---|
|
|
|---|
2. Schuler G, Hambrecht R, Schlierf G, et al. Myocardial perfusion and regression of coronary artery disease in patients on a regime of intensive physical exercise and low fat diet. J Am Coll Cardiol. 1992;19:3442.[Abstract]
3. Ornish D, Brown SE, Scherwitz LW, et al. Can lifestyle changes reverse coronary heart disease: the Lifestyle Heart Trial. Lancet. 1990;336:129133.[Medline] [Order article via Infotrieve]
4.
Ornish D, Scherwitz
LW, Billings JH, et al. Intensive lifestyle changes for reversal of
coronary heart disease. JAMA. 1998;280:20012007.
5.
Haskell WL,
Alderman EL, Fair JM, et al. Effects of intensive multiple risk factor
reduction on coronary atherosclerosis and clinical cardiac events in
men and women with coronary artery disease: the Stanford Coronary Risk
Intervention Project (SCRIP)Circulation. 1994;89:975990.
6.
Schuler G,
Hambrecht R, Schlierf G, et al. Regular physical exercise and low-fat
diet. Effects on progression of coronary artery disease.
Circulation. 1992;86:111.
7.
Niebauer J,
Hambrecht R, Velich T, et al. Attenuated progression of coronary artery
disease after 6 years of multifactorial risk intervention: role of
physical exercise. Circulation. 1997;96:25342541.
8. Hambrecht R, Niebauer J, Marburger C, et al. Various intensities of leisure time physical activity in patients with coronary artery disease: effects on cardiorespiratory fitness and progression of coronary atherosclerotic lesions. J Am Coll Cardiol. 1993;22:468477.[Abstract]
9.
Scheel KW, Ingram
LA, Wilson JL. Effects of exercise on coronary collateral vasculature
of beagles with and without coronary occlusion.
Circ Res. 1981;48:523530.
10.
Cohen MV,
Yipintsoi T, Scheuer J. Coronary collateral stimulation by exercise in
dogs with stenotic coronary arteries.
J Appl Physiol. 1982;52:664671.
11.
Neill WA,
Oxendine JM. Exercise can promote coronary collateral development
without improving perfusion of ischemic myocardium.
Circulation. 1979;60:15131519.
12.
Belardinelli R,
Georgiou D, Ginzton L, et al. Effects of moderate exercise training on
thallium uptake and contractile response to low-dose dobutamine of
dysfunctional myocardium in patients with ischemic cardiomyopathy.
Circulation. 1998;97:553561.
13. Niebauer J, Hambrecht R, Marburger C, et al. Impact of intensive physical exercise and low-fat diet on collateral vessel formation in stable angina pectoris and angiographically confirmed coronary artery disease. Am J Cardiol. 1995;76:771775.[Medline] [Order article via Infotrieve]
14. Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 1986;315:10461051.[Abstract]
15. Harrison DG. Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest. 1997;100:21532157.[Medline] [Order article via Infotrieve]
16.
Bogle RG, Baydoun
AR, Pearson JD, et al. Regulation of L-arginine transport and nitric
oxide release in superfused porcine aortic endothelial cells.
J Physiol. 1996;490:229241.
17.
Böger RH,
Bode-Böger SM, Thiele W, et al. Biochemical evidence for impaired
nitric oxide synthesis in patients with peripheral arterial occlusive
disease. Circulation. 1997;95:20682074.
18. Vallance P, Leone A, Calver A, et al. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet.. 1992;339:572575.[Medline] [Order article via Infotrieve]
19. Creager MA, Gallagher SJ, Girerd XJ, et al. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest. 1992;90:12481253.
20. Drexler H, Zeiher AM, Meinzer K, et al. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet. 1991;338:15461550.[Medline] [Order article via Infotrieve]
21.
Hambrecht R,
Hilbrich L, Erbs S, et al. Correction of endothelial dysfunction in
chronic heart failure: additional effects of exercise training and oral
L-arginine supplementation. J Am Coll
Cardiol. 2000;35:706713.
22.
Blum A, Hathaway
L, Mincemoyer R, et al. Oral L-arginine in patients with coronary
artery disease on medical management.
Circulation. 2000;101:21602164.
23. Michel T, Feron O. Nitric oxide synthases: which, where, how, and why? J Clin Invest. 1997;100:21462152.[Medline] [Order article via Infotrieve]
24.
Ju H, Zou R,
Venema VJ, et al. Direct interaction of endothelial nitric oxide
synthase and caveolin-1 inhibits synthase activity.
J Biol Chem. 1997;272:1852218525.
25.
Shaul PW, Smart
EJ, Robinson LJ, et al. Acylation targets endothelial nitric oxide
synthase to plasmalemmal caveolae. J
Biol Chem. 1996;271:65186522.
26. Harrison DG, Venema RC, Arnal JF, et al. The endothelial cell nitric oxide synthase: is it really constitutively expressed? Agents Actions. 1995;45:107117.
27. Wilcox JN, Subramanian RR, Sundell C, et al. Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler Thromb Vasc Biol. 1997;11:24792488.
28. Nakayama T, Soma M, Takahashi Y, et al. Association analysis of CA repeat polymorphism of the endothelial nitric oxide synthase gene with essential hypertension in Japanese. Clin Genet. 1997;51:2630.[Medline] [Order article via Infotrieve]
29. Rajagopalan S, Meng XP, Ramasamy S, et al. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro: implications for atherosclerotic plaque stability. J Clin Invest. 1996;98:25722579.[Medline] [Order article via Infotrieve]
30.
Wang HD, Pagano
PJ, Du Y, et al. Superoxide anion from the adventitia of the rat
thoracic aorta inactivates nitric oxide.
Circ Res. 1998;82:810818.
31.
Gokce N, Keaney
JF, Frei B, et al. Long-term ascorbic acid administration reverses
endothelial vasomotor dysfunction in patients with coronary artery
disease. Circulation. 1999;99:32343240.
32.
Landmesser U,
Merten R, Spiekermann S, et al. Vascular extracellular superoxide
dismutase activity in patients with coronary artery disease: relation
to endothelium-dependent vasodilation.
Circulation. 2000;101:22642270.
33. Fukai T, Siegfried MR, Ushio-Fukai M, et al. Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. J Clin Invest. 2000;105:16311639.[Medline] [Order article via Infotrieve]
34. Kojda G, Burchfield JS, Cheng YC, et al. Exercise and eNOS expression: the effect of loss of one eNOS gene. Circulation. 1999;100:I-337. Abstract.
35. Posch K, Schmidt K, Graier WF. Selective stimulation of L-arginine uptake contributes to shear stress-induced formation of nitric oxide. Life Sci. 1999;64:663670.[Medline] [Order article via Infotrieve]
36.
Corson MA, James
ML, Latta SE, et al. Phosphorylation of endothelial nitric oxide
synthase in response to fluid shear stress.
Circ Res. 1996;79:984991.
37. Fulton D, Gratton JP, McCabe TJ, et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature. 1999;399:597601.[Medline] [Order article via Infotrieve]
38. Dimmeler S, Fleming I, Fisslthaler B, et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature. 1999;399:601605.[Medline] [Order article via Infotrieve]
39.
Ranjan V, Xiao Z,
Diamond SL. Constitutive NOS expression in cultured endothelial cells
is elevated by fluid shear stress. Am
J Physiol. 1995;269:H550H555.
40.
Noris M, Morigi
M, Donadelli R, et al. Nitric oxide synthesis by cultured endothelial
cells is modulated by flow conditions.
Circ Res. 1995;76:536543.
41.
Sessa WC,
Pritchard K, Seyedi N, et al. Chronic exercise in dogs increases
coronary vascular nitric oxide production and endothelial cell nitric
oxide synthase gene expression. Circ
Res. 1994;74:349353.
42. Woodman CR, Muller JM, Laughlin MH, et al. Induction of nitric oxide synthase mRNA in coronary resistance arteries isolated from exercise-trained pigs. Am J Physiol. 1997;273:H2575H2579.
43.
Ji LL.
Antioxidants and oxidative stress in exercise.
Proc Soc Exp Biol Med. 1999;222:283292.
44.
Hambrecht R, Wolf
A, Gielen S, et al. Effect of exercise on coronary endothelial function
in patients with coronary artery disease.
N Engl J Med. 2000;342:454460.
45.
Griffin KL,
Laughlin MH, Parker JL. Exercise training improves endothelium-mediated
vasorelaxation after chronic coronary occlusion.
J Appl Physiol. 1999;87:19481956.
46. Rubio R, Berne RM. Regulation of coronary blood flow. Prog Cardiovasc Dis. 1975;18:105122.[Medline] [Order article via Infotrieve]
47.
Altman JD, Kinn
J, Duncker DJ, et al. Effect of inhibition of nitric oxide formation on
coronary blood flow during exercise in the dog.
Cardiovasc Res. 1994;28:119124.
48.
Kostic MM,
Schrader J. Role of nitric oxide in reactive hyperemia of the guinea
pig heart. Circ Res. 1992;70:208212.
49.
DiCarlo SE, Blair
RW, Bishop VS, et al. Daily exercise enhances coronary resistance
vessel sensitivity to pharmacological activation.
J Appl Physiol. 1989;66:421428.
50.
Muller JM, Myers
PR, Laughlin MH. Vasodilator responses of coronary resistance arteries
of exercise-trained pigs.
Circulation. 1994;89:23082314.
51. Huxley VH, Williams DA, Meyer DJ Jr, et al. Altered basal and adenosine-mediated protein flux from coronary arterioles isolated from exercise-trained pigs. Acta Physiol Scand. 1997;160:315325.[Medline] [Order article via Infotrieve]
52.
White FC, Bloor
CM, McKirnan MD, et al. Exercise training in swine promotes growth of
arteriolar bed and capillary angiogenesis in heart.
J Appl Physiol. 1998;85:11601168.
53. Ernst E. Influence of regular physical activity on blood rheology. Eur Heart J. 1987;8(suppl G):5962.
54. Reinhart WH, Dziekan G, Goebbels U, et al. Influence of exercise training on blood viscosity in patients with coronary artery disease and impaired left ventricular function. Am Heart J. 1998;135:379382.[Medline] [Order article via Infotrieve]
55. Prisco D, Francalanci I, Filippini M, et al. Physical exercise and hemostasis. Int J Clin Lab Res. 1994;24:125131.[Medline] [Order article via Infotrieve]
56.
Wang JS, Jen CJ,
Chen HI. Effects of exercise training and deconditioning on platelet
function in men. Arterioscler Thromb Vasc
Biol. 1995;15:16681674.
57. Suzuki T, Yamauchi K, Yamada Y, et al. Blood coagulability and fibrinolytic activity before and after physical training during the recovery phase of acute myocardial infarction. Clin Cardiol. 1992;15:358364.[Medline] [Order article via Infotrieve]
58.
Johnstone MT,
Creager SJ, Scales KM, et al. Impaired endothelium-dependent
vasodilation in patients with insulin-dependent diabetes mellitus.
Circulation. 1993;88:25102516.
59. Chowienczyk PJ, Watts GF, Cockroft JR, et al. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet. 1992;340:14301432.[Medline] [Order article via Infotrieve]
60.
Treasure CB,
Manoukian SV, Klein JL, et al. Epicardial coronary artery responses to
acetylcholine are impaired in hypertensive patients.
Circ Res. 1992;71:776781.
61. Nitenberg A, Antony I, Foult JM. Acetylcholine-induced coronary vasoconstriction in young, heavy smokers with normal coronary angiographic findings. Am J Med. 1993;95:7177.[Medline] [Order article via Infotrieve]
62.
Sumida H,
Watanabe H, Kugiyama K, et al. Does passive smoking impair
endothelium-dependent coronary artery dilation in women?
J Am Coll Cardiol. 1998;31:811815.
63.
Suwaidi JA,
Hamasaki S, Higano ST, et al. Long-term follow-up of patients with mild
coronary artery disease and endothelial dysfunction.
Circulation. 2000;101:948954.
64.
Schächinger V,
Britten MB, Zeiher A. Prognostic impact of coronary vasodilator
dysfunction on adverse long-term outcome of coronary heart disease.
Circulation. 2000;101:18991906.
This article has been cited by other articles:
![]() |
N. Thengchaisri, R. Shipley, Y. Ren, J. Parker, and L. Kuo Exercise Training Restores Coronary Arteriolar Dilation to NOS Activation Distal to Coronary Artery Occlusion: Role of Hydrogen Peroxide Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 791 - 798. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Abrams Chronic Stable Angina N. Engl. J. Med., June 16, 2005; 352(24): 2524 - 2533. [Full Text] [PDF] |
||||
![]() |
K. L. Griffin, C. R. Woodman, E. M. Price, M. H. Laughlin, and J. L. Parker Endothelium-Mediated Relaxation of Porcine Collateral-Dependent Arterioles Is Improved by Exercise Training Circulation, September 18, 2001; 104(12): 1393 - 1398. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |